November 6, 2024
TOPLINE: Patients with cancer who receive immune checkpoint inhibitors (ICIs) have more than twice the risk for developing psoriasis compared with those who receive other treatments. […]
November 5, 2024
TOPLINE: An estimated 72 million ambulatory visits for superficial cutaneous fungal infections (SCFIs) in the United States were recorded during 2005-2016, with an increasing trend over […]
November 4, 2024
(Reuters) -Journey Medical said on Monday the U.S. Food and Drug Administration has approved its drug for the treatment of a long-term skin condition called rosacea. […]
November 4, 2024
AMSTERDAM — The monoclonal antibody bimekizumab (Bimzelx) achieves significant and clinically meaningful improvements in moderate to severe hidradenitis suppurativa (HS) that are maintained well beyond the […]
November 4, 2024
Implementing the Patient Health Questionnaire-2 (PHQ-2) in a hidradenitis suppurativa (HS) clinic improved the ability of dermatologists to detect patients at risk for depression, results from […]
November 4, 2024
Individuals with hidradenitis suppurativa (HS) face a significantly increased risk for bulimia nervosa and binge eating disorder, an analysis of national data showed. Christopher Guirguis, DMD […]
November 1, 2024
TOPLINE: The British Association of Dermatologists is alerting the public and clinicians about an unusual increase in scabies cases thus far this year. METHODOLOGY: The British […]
November 1, 2024
TOPLINE: Between 2011 and 2023, the US Food and Drug Administration (FDA) reported recalls of 334 cosmetic dermatology products in the United States, affecting over 77 […]
October 31, 2024
TOPLINE: Patients with cutaneous lupus erythematosus (CLE) experienced improved symptoms with iberdomide, a cereblon modulator, added to standard lupus medications, particularly in subacute and chronic cases. […]